QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 153 filers reported holding QIAGEN NV in Q2 2013. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $514,000 | -13.8% | 18,355 | -15.5% | 0.02% | -26.7% |
| Q3 2016 | $596,000 | +18.5% | 21,726 | -5.8% | 0.03% | +66.7% |
| Q2 2016 | $503,000 | -4.4% | 23,052 | -2.1% | 0.02% | -10.0% |
| Q1 2016 | $526,000 | -64.5% | 23,538 | -56.1% | 0.02% | -28.6% |
| Q4 2015 | $1,482,000 | +15.9% | 53,613 | +8.1% | 0.03% | +3.7% |
| Q3 2015 | $1,279,000 | -4.2% | 49,578 | -7.9% | 0.03% | +8.0% |
| Q2 2015 | $1,335,000 | -4.1% | 53,859 | -2.5% | 0.02% | -3.8% |
| Q1 2015 | $1,392,000 | +7.4% | 55,247 | 0.0% | 0.03% | +8.3% |
| Q4 2014 | $1,296,000 | +13.5% | 55,247 | +10.2% | 0.02% | +4.3% |
| Q3 2014 | $1,142,000 | -18.3% | 50,147 | -11.6% | 0.02% | -14.8% |
| Q2 2014 | $1,398,000 | +14.7% | 56,737 | -0.7% | 0.03% | +12.5% |
| Q1 2014 | $1,219,000 | -42.7% | 57,135 | -36.1% | 0.02% | -14.3% |
| Q4 2013 | $2,128,000 | +4.9% | 89,412 | -5.7% | 0.03% | 0.0% |
| Q3 2013 | $2,028,000 | -6.2% | 94,783 | -12.7% | 0.03% | +3.7% |
| Q2 2013 | $2,163,000 | – | 108,633 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tikvah Management LLC | 369,425 | $9,032,000 | 6.36% |
| Hardman Johnston Global Advisors LLC | 4,586,856 | $112,149,000 | 5.99% |
| Eclectica Asset Management LLP | 90,950 | $2,223,000 | 2.21% |
| Douglas C. Lane & Associates, Inc. | 1,970,371 | $48,176,000 | 1.46% |
| HARDING LOEVNER LP | 6,978,369 | $170,621,000 | 1.27% |
| CRAMER ROSENTHAL MCGLYNN LLC | 3,911,835 | $95,644,000 | 0.77% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,781,076 | $43,547,000 | 0.76% |
| GLG Partners LP | 1,220,148 | $29,833,000 | 0.71% |
| Sivik Global Healthcare LLC | 49,451 | $1,209,000 | 0.61% |
| PRIMECAP MANAGEMENT CO/CA/ | 22,087,404 | $540,037,000 | 0.59% |